Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
05/27/2024 12:20 PM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20230&cosponId=40371
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2023 - 2024 Regular Session

MEMORANDUM

Posted: March 30, 2023 06:05 PM
From: Representative Tarik Khan and Rep. Malcolm Kenyatta, Rep. Bridget M. Kosierowski, Rep. Rick Krajewski, Rep. Greg Scott
To: All House members
Subject: Improving Pennsylvanians’ Access to HIV Prevention
 
Today's ruling by the Texas Supreme Court targets access to HIV preventive services and jeopardizes coverage for millions of Pennsylvanians. Currently, there are 40,600 individuals in Pennsylvania living with HIV. In 2021, there were nearly 1,000 new HIV diagnoses among adults and adolescents in the Commonwealth. Although no cure is currently available for HIV, certain antiretroviral medications can help to prevent the transmission of the disease. Pre-exposure prophylaxis (PrEP) is available to individuals who are HIV-negative to prevent HIV. Post-exposure prophylaxis (PEP) is available to individuals potentially exposed to HIV. 

Unfortunately, these medications can often be too expensive for the average resident in the Commonwealth. Brand name PrEP medication averages roughly $2,400 for a 30-day supply, and PEP medication ranges from $600 to $1,000 for a 28-day supply. Along with the need for medication are the quarterly lab tests and healthcare provider visits that can total $15,000 a year. Although generic competition has reduced the average cost of daily oral PrEP to less than $20 per month, many insurers still place unnecessary barriers to coverage.

To increase accessibility for these medications, we will introduce legislation ensuring health insurance policies cover PrEP and PEP medications, the cost of associated recommended lab tests, and patient visits to a healthcare provider to have PrEP and PEP prescribed or maintained. 

PrEP and PEP are considered life-saving medications and should be readily available to those in need without the added worry of the price of the medication, lab tests, or healthcare provider visits. Please join us by co-sponsoring this important legislation that would provide Pennsylvanians with access to essential medications that prevent HIV infection.
 



Introduced as HB1213